Nuveen Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $3.55M | Sell |
95,665
-112,307
| -54% | -$4.17M | ﹤0.01% | 2135 |
|
2024
Q3 | $10.1M | Sell |
207,972
-93,617
| -31% | -$4.54M | ﹤0.01% | 1599 |
|
2024
Q2 | $12.1M | Buy |
301,589
+114,098
| +61% | +$4.56M | ﹤0.01% | 1473 |
|
2024
Q1 | $8.23M | Sell |
187,491
-2,356
| -1% | -$103K | ﹤0.01% | 1722 |
|
2023
Q4 | $11.7M | Sell |
189,847
-164,112
| -46% | -$10.2M | ﹤0.01% | 1494 |
|
2023
Q3 | $16.3M | Sell |
353,959
-20,560
| -5% | -$946K | 0.01% | 1163 |
|
2023
Q2 | $21.5M | Buy |
374,519
+56,195
| +18% | +$3.23M | 0.01% | 1024 |
|
2023
Q1 | $11.9M | Sell |
318,324
-65,681
| -17% | -$2.46M | ﹤0.01% | 1372 |
|
2022
Q4 | $10.8M | Sell |
384,005
-32,602
| -8% | -$913K | ﹤0.01% | 1439 |
|
2022
Q3 | $11.7M | Sell |
416,607
-174,217
| -29% | -$4.9M | ﹤0.01% | 1383 |
|
2022
Q2 | $20.6M | Buy |
590,824
+114,149
| +24% | +$3.97M | 0.01% | 1031 |
|
2022
Q1 | $16.9M | Buy |
476,675
+93,448
| +24% | +$3.31M | 0.01% | 1296 |
|
2021
Q4 | $8.26M | Buy |
383,227
+9,175
| +2% | +$198K | ﹤0.01% | 1811 |
|
2021
Q3 | $6.87M | Sell |
374,052
-45,085
| -11% | -$828K | ﹤0.01% | 2041 |
|
2021
Q2 | $8.45M | Buy |
419,137
+243,749
| +139% | +$4.91M | ﹤0.01% | 1969 |
|
2021
Q1 | $3.21M | Sell |
175,388
-11,172
| -6% | -$205K | ﹤0.01% | 2385 |
|
2020
Q4 | $3.75M | Sell |
186,560
-18,626
| -9% | -$375K | ﹤0.01% | 2219 |
|
2020
Q3 | $3.85M | Buy |
205,186
+20,651
| +11% | +$387K | ﹤0.01% | 2055 |
|
2020
Q2 | $4.15M | Buy |
184,535
+46,580
| +34% | +$1.05M | ﹤0.01% | 2003 |
|
2020
Q1 | $2.05M | Sell |
137,955
-390
| -0.3% | -$5.79K | ﹤0.01% | 2173 |
|
2019
Q4 | $2.67M | Sell |
138,345
-165,026
| -54% | -$3.18M | ﹤0.01% | 2306 |
|
2019
Q3 | $6.02M | Sell |
303,371
-271,412
| -47% | -$5.38M | ﹤0.01% | 1863 |
|
2019
Q2 | $12.1M | Buy |
+574,783
| New | +$12.1M | ﹤0.01% | 1477 |
|